Pharma pulled in big Lions Health audiences with play-by-play case studies and frank talk. Dying commercial model? Creepy big data? Yes, and more.
Cannes means creativity in the advertising world, but pharma is still sitting on the sidelines.
The positive data for Roche’s Ocrevus keep on coming.
It’s a two-fer for McCann Health. The agency won Cannes Lions Health network advertising agency of the year for the second year in a row.
Shire nabbed FDA approval Wednesday for its new long-acting ADHD drug Mydayis, and it's targeting $500 million in sales by 2020.
After scoring impressive numbers with its science-focused TV ad, Pfizer is preparing to launch another next month starring one of its own scientists.
Hands do the talking in new TV commercials for an Endo disease awareness campaign highlighting Dupuytren's contracture.
There’s a new FDA-approved ADHD medication on the scene, and it’s one maker Neos Therapeutics thinks will put it in prime market position.
What did Lions Health festivalgoers take home? Concrete ideas—such as the winning campaigns—but also that nebulous feeling we call “inspiration.”
No one travels to an industry gathering without expectations, but at the Cannes Lions Health Festival, attendees set some pretty lofty goals.